Pulmonary hypertension, defined as an elevation in blood pressure in the pulmonary
arteries, is associated with an increased risk of death. The prevalence of pulmonary …

Abstract In February 2018, the 6th World Symposium on Pulmonary Hypertension (WSPH)
brought together experts from various disciplines to review the most relevant clinical and …

Eight years have passed since the publication of the only guideline on cardiac rehabilitation
(CR) in Japan,“Guidelines for rehabilitation in patients with cardiovascular disease (JCS …

Background: Coronavirus (Covid-19) infection represents a serious medical condition, often
associated with cardiovascular complications, pulmonary hypertension (PH), and right …

Pulmonary arterial hypertension (PAH) is a severe cardiopulmonary dysfunctional disease,
characterized by progressive vascular remodeling. Inflammation is an increasingly …

Background There are limited data about the range of diseases, natural history, age-
appropriate end-points and optimal care for children with pulmonary hypertension (PH) …

Pulmonary arterial hypertension (PAH) is a progressive and fatal lung disease of
multifactorial etiology. Most of the available drugs and FDA-approved therapies for treating …

ISHLT members have recognized the importance of a consensus statement on the
evaluation and management of patients with chronic thromboembolic pulmonary …

Pulmonary arterial hypertension is a devastating progressive disease mediated by different
pathophysiologic pathways that result in progressive increase in pulmonary vascular …

Pulmonary arterial hypertension is a progressive fatal disease that is characterized by
pathological pulmonary artery remodeling, in which endothelial cell dysfunction is critically …